Literature DB >> 26450068

Box and block test in Beninese adults.

Ditouah Didier Niama Natta1, Etienne Alagnidé, Toussaint Godonou Kpadonou, Christine Detrembleur, Thierry M Lejeune, Gaëtan G Stoquart.   

Abstract

OBJECTIVE: To determine the Box and Block Test norm in a sub-Saharan population and to compare these data with published norms for North American adults.
METHODS: A total of 692 healthy Beninese people, age range 20-85 years, were recruited. These subjects were asked to perform the Box and Block Test with both hands.
RESULTS: Box and Block Test scores (mean and standard deviation (SD)) for women and men were, respectively, 81.3 (15.4) and 79 (16.6) for the dominant hand and 73.2 (13.7) and 72 (14.8) for the non-dominant hand. Mean Box and Block Test scores ranged from 89.1 (12.7) for people under the age of 25 years to 55.23 (10.5) for people over the age of 74 years. DISCUSSION: Manual dexterity was better for women than men, for dominant hand than non-dominant hand, and for younger subjects. In comparison with published results for US subjects, Beninese subjects had better dexterity below the age of 50 years in both sexes for the right hand and worse dexterity over 64 years of age in both sexes for the right hand.
CONCLUSION: Developing and validating outcome scales in Africa will help to improve functional assessment of African populations in clinical practice and research.

Entities:  

Mesh:

Year:  2015        PMID: 26450068     DOI: 10.2340/16501977-2023

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  1 in total

1.  Concurrent validity of an immersive virtual reality version of the Box and Block Test to assess manual dexterity among patients with stroke.

Authors:  Gauthier Everard; Yasmine Otmane-Tolba; Zélie Rosselli; Thomas Pellissier; Khawla Ajana; Stéphanie Dehem; Edouard Auvinet; Martin Gareth Edwards; Julien Lebleu; Thierry Lejeune
Journal:  J Neuroeng Rehabil       Date:  2022-01-22       Impact factor: 4.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.